# ArchiMed acquires DIESSE Diagnostica Senese for €14.5 million

MED II, managed by ArchiMed SAS, completed the acquisition of DIESSE Diagnostica Senese S.p.A. from Orphée SA and founders for €14.5 million on May 13, 2019. The deal included 13.5 million Class A shares for €13.3 million.

- Type: Acquisition
- Announced: 2019-05-01
- Where: Siena, Italy
- Value: $16.2M (14.5M EUR)
- Status: completed
- Products: diagnostic products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [ARCHIMED](https://endata.com/companies/34181.md) (acquirer)
- [DIESSE Diagnostica Senese](https://endata.com/companies/38961.md) (target)
- [Orphée SA](https://endata.com/companies/38962.md) (partner)
- [Duomodiag Sarl](https://endata.com/companies/41179.md) (acquirer)
- [PZ Cormay SA](https://endata.com/companies/41180.md) (partner)

## Sources

- [marketscreener.com](https://www.marketscreener.com/quote/stock/ORPHEE-SA-20707834/news/MED-II-managed-by-ArchiMed-SAS-completed-the-acquisition-of-DIESSE-Diagnostica-Senese-S-p-A-from-O-34302463/), 2019-05-12: "MED II, managed by ArchiMed SAS completed the acquisition of DIESSE Diagnostica Senese S.p.A. from Orphée SA and founders for €14.5 million."
- [lawyer-monthly.com](https://www.lawyer-monthly.com/2019/08/archimed-acquires-in-vitro-diagnostics/), 2019-08-06: "ArchiMed announces the purchase of Diesse Diagnostica Senese SpA (‘Diesse’) by Duomodiag Sarl, a holding company backed by ArchiMed through its MED II fund."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.